Previous Article | Next Article ![]()
Molecular and Cellular Biology, September 2000, p. 6342-6353, Vol. 20, No. 17
Terry Fox Molecular Oncology Group, Lady
Davis Institute for Medical Research,1 and
Departments of Microbiology and
Immunology3 and
Medicine,2 McGill University, Montreal,
Quebec, Canada H3T 1E2
Received 27 January 2000/Returned for modification 22 March
2000/Accepted 2 June 2000
Recent studies implicate the interferon (IFN) regulatory factors
(IRF) IRF-3 and IRF-7 as key activators of the alpha/beta IFN
(IFN-
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Selective DNA Binding and Association with the CREB Binding
Protein Coactivator Contribute to Differential Activation of
Alpha/Beta Interferon Genes by Interferon Regulatory Factors 3 and 7
/
) genes as well as the RANTES chemokine gene. Using coexpression analysis, the human IFNB, IFNA1, and RANTES promoters were
stimulated by IRF-3 coexpression, whereas the IFNA4, IFNA7, and IFNA14
promoters were preferentially induced by IRF-7 only. Chimeric proteins
containing combinations of different IRF-7 and IRF-3 domains were
also tested, and the results provided evidence of distinct DNA binding
properties of IRF-3 and IRF-7, as well as a preferential association of
IRF-3 with the CREB binding protein (CBP) coactivator. Interestingly,
some of these fusion proteins led to supraphysiological levels of IFN
promoter activation. DNA binding site selection studies demonstrated
that IRF-3 and IRF-7 bound to the 5'-GAAANNGAAANN-3'
consensus motif found in many virus-inducible genes; however, a
single nucleotide substitution in either of the GAAA half-site motifs
eliminated IRF-3 binding and transactivation activity but did not
affect IRF-7 interaction or transactivation activity. These studies
demonstrate that IRF-3 possesses a restricted DNA binding site
specificity and interacts with CBP, whereas IRF-7 has a broader DNA
binding specificity that contributes to its capacity to stimulate
delayed-type IFN gene expression. These results provide an explanation
for the differential regulation of IFN-
/
gene expression by IRF-3
and IRF-7 and suggest that these factors have complementary rather than
redundant roles in the activation of the IFN-
/
genes.
*
Corresponding author. Mailing address: Lady Davis
Institute for Medical Research, 3755 Cote Ste. Catherine, Montreal,
Quebec, Canada H3T 1E2. Phone: (514) 340-8222, ext. 3169. Fax: (514)
340-7576. E-mail: mdli{at}musica.mcgill.ca.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|